MyFinsight
Home
Blog
About
Contact
Download
Download image
Property and equipment,
gross
$5,614K
Prepaid expenses and
other current assets
$9,186K
Inventory
$4,038K
Accounts receivable, net
$26,178K
Investments
$3,204K
Cash and cash
equivalents
$60,540K
Other assets
$267K
Restricted cash
$351K
Operating lease
right-of-use assets
$4,548K
Property and equipment,
net
$104K
Total current assets
$103,146K
Less accumulated
depreciation and...
$5,510K
Total assets
$108,416K
Accumulated deficit
-$1,759,499K
Total liabilities and
stockholders' deficit
$108,416K
Total stockholders'
deficit
-$292,926K
Accumulated other
comprehensive income (loss)
$71K
Additional paid-in capital
$1,466,488K
Common stock, 0.0001
par value 53,333...
$14K
Total liabilities
$401,342K
Other liabilities
$11,095K
Operating lease
liabilities, net of current...
$5,743K
Common stock warrants
$14,221K
Deferred royalty
obligation
$72,338K
Senior secured term
loan, net of current...
$94,795K
Convertible senior notes due
2028
$21,117K
Convertible senior notes due
2029
$89,973K
Total current
liabilities
$92,060K
Other current
liabilities
$1,580K
Operating lease
liabilities
$969K
Senior secured term
loan
$21,010K
Accrued expenses
$64,498K
Accounts payable
$4,003K
Back
Back
Balance Sheet
source: myfinsight.com
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)